Developer docs
API playgroundTry for free, no card

Search company profiles

Pharma Boardroom

Full company profile

uuid000bpfk

Namestring
Pharma Boardroom
Legal namestring
PharmaBoardroom Limited
Company typeenum
Private
Founded yearint
2012
Descriptiontext

PharmaBoardroom is a B2B content and insights platform serving senior decision-makers in the global pharmaceutical and life sciences industry. Headquartered in Norwich, United Kingdom and operating as PharmaBoardroom Limited (a UK private limited company), the platform distributes country-specific market intelligence, exclusive executive interviews, legal/regulatory handbooks, and statistical data products to a community of 26,000+ decision-makers, over half of whom are C-level executives. The company is led by CEO and Publisher Diana Viola and maintains regional leadership across EMEA, Asia, and the Americas.

The company's core products include Country Reports (multi-region pharma market analyses), In Conversation interviews with CEOs and policymakers, Articles, The Pharma Legal Handbook (country-specific legal and regulatory guides co-developed with leading national law firms), Market Access & HTA Reports, the InFigures statistical data and rankings product, and InFocus thematic e-books. The platform runs on a WordPress publishing stack (pharmaboardroom.com) with a gated membership wall, supplemented by a Shopify e-commerce storefront (pharmaboardroom.myshopify.com) for individual report and e-book purchases. Distribution is driven by weekly email newsletters, LinkedIn, and the proprietary web platform.

PharmaBoardroom generates revenue through two primary streams: recurring paid subscriptions/memberships granting access to gated premium content, and one-time perpetual licenses for individual country reports, legal handbooks, and e-books priced at GBP 75-149 per item. The co-publishing model with 11+ leading national law firms (including Baker McKenzie, Nishimura & Asahi, Fangda Partners, TGS Baltic, ABNR, and others) is a structural feature of content production, particularly for legal/regulatory handbooks across jurisdictions in Europe, Asia-Pacific, the Americas, and the Middle East & Africa. The company has been operating for over two decades, with no disclosed external funding, no parent company, and no evidence of institutional or venture capital ownership.

Short descriptiontext

PharmaBoardroom is a UK-based B2B content and insights platform for the global pharmaceutical and life sciences industry, distributing country reports, executive interviews, legal handbooks, and statistical data products to a 26,000+ member community of senior decision-makers across 100+ countries via subscription and individual report sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNorwich, United Kingdom
HQ citystring
Norwich
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical market intelligence, healthcare industry research, pharma regulatory guides, market access reports, pharma legal handbooks
Industry1 code
PRIMARYHLAIAKAK
Pricing Operations & Analytics (Price Governance, Systems, Reporting)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
NAICS code3 codes
  • Newspaper, Periodical, Book, and Directory Publishers5131
  • Book Publishers513130
  • Directory and Mailing List Publishers513140
SIC code1 code
  • Books: Publishing Or Publishing & Printing2731
Product category
Pharmaceutical Market Intelligence
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Subscription Membership
TypeSubscription Recurring
Description

The company operates a membership-based model where users must register and sign in to access premium content including reports, interviews, and articles. The registration form indicates subscription terms with automatic renewal at the end of each subscription period.

pharmaboardroom.com
2Report Sales
TypeOne Time License
Description

PharmaBoardroom sells country-specific reports, legal handbooks, and e-books through their Shopify-powered shop. Reports include Country Reports, The Pharma Legal Handbook series, and InFocus e-books covering topics like China biotech catalysts, rare diseases, and regional healthcare trends. Prices range from GBP 75-149 for legal handbooks.

pharmaboardroom.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Others, Technology or R&D
Pricing details2 tiers
1Pharma Legal Handbook Country Reports - Individual country legal guides
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Prices range from GBP 75 to GBP 149 per report depending on country complexity. Examples include Serbia at GBP 75, Slovakia at GBP 75, Poland at GBP 119, Denmark at GBP 119, Japan at GBP 149.

pharmaboardroom.com
2Market Access & HTA Country Reports
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Sold through Shopify at varying price points for market access and health technology assessment guides by country.

pharmaboardroom.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

PharmaBoardroom produces and sells subscription-based market intelligence for the global pharmaceutical and life sciences industry. Its portfolio includes Country Reports, exclusive executive interviews, The Pharma Legal Handbook series, Market Access & HTA Reports, InFigures statistical datasets, and InFocus e-books covering therapeutic areas and regional market trends across 100+ countries. Premium content is gated behind paid membership, with individual reports and handbooks also sold via a Shopify storefront.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

PharmaBoardroom is a content and insights platform for the healthcare and life sciences industry, offering a portfolio of content products including Country Reports (country-specific pharmaceutical market analyses), Interviews (exclusive conversations with industry leaders), Articles (news and analysis), The Pharma Legal Handbook (legal and regulatory guides), Market Access & HTA Reports (reimbursement and pricing information), InFigures (statistical data and rankings), InFocus (in-depth e-books), White Papers, and Contributions (opinion content). The platform operates on a subscription model providing access to premium reports and exclusive content to its community of over 26,000 decision-makers, including C-level executives, across the global pharmaceutical industry.

Product and service6 records
1Country Reports
CategoryMarket Intelligence Reports
Description

Comprehensive country-specific reports covering pharmaceutical markets, healthcare systems, and life sciences industries across the Americas, Asia-Pacific, Europe, and Middle East & Africa, targeted at pharma, biotech, and healthcare decision-makers.

2The Pharma Legal Handbook
CategoryLegal and Regulatory Guides
Description

Comprehensive country-specific legal and regulatory guides covering pharmaceutical law, pricing, reimbursement, marketing, manufacturing, patents, and clinical trial requirements, co-developed with leading national law firms and sold individually (GBP 75-149).

3Market Access & HTA Reports
CategoryMarket Access and Reimbursement Intelligence
Description

Country-specific market access and health technology assessment guides covering pricing systems, reimbursement frameworks, managed entry agreements, and healthcare system structures, targeted at market access and HEOR professionals.

4InFigures
CategoryStatistical Data and Rankings
Description

Statistical data and rankings including market data, company rankings, regulatory statistics, and pharmaceutical industry metrics across global markets.

5InFocus (E-books)
CategoryThematic E-books
Description

In-depth focused reports and e-books on specific therapeutic areas, technologies, and regional market trends including cell & gene therapy, precision medicine, rare diseases, and China biotech catalysts.

6Subscription/Membership
CategorySubscription Membership
Description

Paid annual membership providing access to full reports, downloads, exclusive content, and newsletter subscriptions, with automatic renewal at the end of each subscription period.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Legal handbook content partnership. BDK Advokati, a leading Serbian law firm, co-prepared The Pharma Legal Handbook: Serbia, answering questions about legal and regulatory environment for pharmaceuticals in Serbia including regulation, pricing, clinical trials, marketing, manufacturing, trademarks and patents.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Legal handbook content partnership. TEGOS, a leading Baltic law firm, co-prepared The Pharma Legal Handbook: Asia Growth & Transition Market covering Estonia, Latvia and Lithuania, addressing regulation, pricing, clinical and preclinical trials, marketing, manufacturing, trademarks and patents.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Legal handbook content partnership. PRK Partners, a leading Czech and Slovak law firm, co-prepared The Pharma Legal Handbooks for Slovakia and Czech Republic, covering regulation, pricing, clinical trials, marketing, manufacturing, trademarks, patents, medical cannabis and opioids.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Legal handbook content partnership. Mușat & Asociații, one of Romania's leading corporate law firms, co-developed the Pharma Legal Handbook: Market Access & HTA Romania, a comprehensive country-specific market access and health technology assessment guide.

5ABNR (Indonesia)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Legal handbook content partnership. ABNR, a leading Indonesian law firm, co-prepared The Pharma Legal Handbook: Asia Growth & Transition Market covering Indonesia.

pharmaboardroom.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Legal handbook content partnership. Youssry Saleh Law Firm, a leading Saudi Arabia law firm, co-prepared the Market Access & Health Technology Assessment: Saudi Arabia guide.

7Nishimura & Asahi (Japan)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Legal handbook content partnership. Nishimura & Asahi, a leading Japanese law firm, co-prepared the Market Access & Health Technology Assessment: Japan guide.

pharmaboardroom.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Legal handbook content partnership. Trench Rossi e Watanabe, a leading Brazilian law firm, co-prepared the Market Access & Health Technology Assessment: Brazil guide.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Legal handbook content partnership. Baker McKenzie, a leading Italian law firm, co-prepared the Market Access & Health Technology Assessment: Italy guide.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Legal handbook content partnership. Fangda Partners, a leading Chinese law firm, contributed regulatory content including preclinical and clinical trial requirements, product liability, healthcare system and funding, regulatory reforms, and localization information for China.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Legal handbook content partnership. TGS Baltic, a leading Baltic law firm, co-prepared The Pharma Legal Handbook: Baltics covering Estonia, Latvia and Lithuania.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1FiercePharma
TypeBroad incumbent
Description

FiercePharma is a leading B2B news and analysis outlet for the pharma industry, covering drug commercialization, market access, and policy. It overlaps directly with PharmaBoardroom's editorial remit and global audience, but operates at much larger scale and is part of a broader healthcare B2B portfolio.

TypeDirect peer
Description

BioPharma Dive is a B2B digital publication providing in-depth news and analysis on the biopharma industry, including commercial, regulatory, and R&D coverage. It serves the same C-suite and decision-maker audience as PharmaBoardroom and follows a similar digital-first, subscription-supported model.

TypeDirect peer
Description

Endpoints News is a B2B publication focused on the biopharma industry with deep reporting, editorial analysis, and subscriber-supported business model. It targets similar senior industry professionals and competes for the same pharma executive attention as PharmaBoardroom.

TypeBroad incumbent
Description

Citeline, part of Informa Pharma Intelligence, is a large pharma intelligence provider offering databases, analytics, and reports on drug development, clinical trials, and market access. It is a much larger incumbent that addresses a similar buyer need - global pharma market and regulatory intelligence - but via paid data platforms rather than editorial content.

TypeBroad incumbent
Description

GlobalData Healthcare provides market intelligence, country reports, and analytics across pharma, biotech, and medtech. It is a direct competitor in the country-specific pharma intelligence segment where PharmaBoardroom sells Country Reports and Market Access & HTA guides, though GlobalData operates at significantly larger scale.

TypeDirect peer
Description

PharmaTimes is a long-running B2B publication covering the global pharmaceutical industry, including interviews with industry leaders, country features, and market access coverage. It is a like-for-like peer to PharmaBoardroom in editorial format and audience, though it is UK-anchored and more focused on European news.

7The Pink Sheet (Citeline)
TypeBroad incumbent
Description

The Pink Sheet is a flagship pharma policy, regulatory, and market access publication now under Citeline/Informa. It is highly comparable to PharmaBoardroom's Pharma Legal Handbook and Market Access & HTA products in content and buyer, but operates as a subscription news service at much larger scale.

TypeDirect peer
Description

Pharmaceutical Executive is a B2B magazine and digital publication serving senior pharma executives with strategy, policy, and market access content. It targets a similar C-suite audience as PharmaBoardroom and competes for the same executive attention and sponsorship dollars.

9PharmaBoardroom's direct/adjacent - Focus Reports (legacy sister brand context)
TypeOthers
Description

Focus Reports appears to share the PharmaBoardroom newsletter infrastructure and content lineage, covering country reports and pharma market analysis. It is a closely related publishing/insights brand rather than a direct competitor.

TypeBroad incumbent
Description

Scrip is a long-established pharma industry news and analysis brand under Citeline/Informa, covering global drug development, commercial strategy, and policy. It competes for the same pharma executive readership as PharmaBoardroom, but at much larger institutional scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pharma Boardroom

Pharmaceutical Market Intelligencepharmaboardroom.com

PharmaBoardroom is a UK-based B2B content and insights platform for the global pharmaceutical and life sciences industry, distributing country reports, executive interviews, legal handbooks, and statistical data products to a 26,000+ member community of senior decision-makers across 100+ countries via subscription and individual report sales.

What Pharma Boardroom does

PharmaBoardroom is a B2B content and insights platform serving senior decision-makers in the global pharmaceutical and life sciences industry. Headquartered in Norwich, United Kingdom and operating as PharmaBoardroom Limited (a UK private limited company), the platform distributes country-specific market intelligence, exclusive executive interviews, legal/regulatory handbooks, and statistical data products to a community of 26,000+ decision-makers, over half of whom are C-level executives. The company is led by CEO and Publisher Diana Viola and maintains regional leadership across EMEA, Asia, and the Americas.

The company's core products include Country Reports (multi-region pharma market analyses), In Conversation interviews with CEOs and policymakers, Articles, The Pharma Legal Handbook (country-specific legal and regulatory guides co-developed with leading national law firms), Market Access & HTA Reports, the InFigures statistical data and rankings product, and InFocus thematic e-books. The platform runs on a WordPress publishing stack (pharmaboardroom.com) with a gated membership wall, supplemented by a Shopify e-commerce storefront (pharmaboardroom.myshopify.com) for individual report and e-book purchases. Distribution is driven by weekly email newsletters, LinkedIn, and the proprietary web platform.

PharmaBoardroom generates revenue through two primary streams: recurring paid subscriptions/memberships granting access to gated premium content, and one-time perpetual licenses for individual country reports, legal handbooks, and e-books priced at GBP 75-149 per item. The co-publishing model with 11+ leading national law firms (including Baker McKenzie, Nishimura & Asahi, Fangda Partners, TGS Baltic, ABNR, and others) is a structural feature of content production, particularly for legal/regulatory handbooks across jurisdictions in Europe, Asia-Pacific, the Americas, and the Middle East & Africa. The company has been operating for over two decades, with no disclosed external funding, no parent company, and no evidence of institutional or venture capital ownership.

Pharma Boardroom firmographics

Firmographics
Name
Pharma Boardroom
Legal name
PharmaBoardroom Limited
Website
https://pharmaboardroom.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
PharmaBoardroom is a UK-based B2B content and insights platform for the global pharmaceutical and life sciences industry, distributing country reports, executive interviews, legal handbooks, and statistical data products to a 26,000+ member community of senior decision-makers across 100+ countries via subscription and individual report sales.
Ownership category
akta.pro rank

Pharma Boardroom industry classification

Industry
Product category
Pharmaceutical Market Intelligence
NAICS
Newspaper, Periodical, Book, and Directory Publishers (5131), Book Publishers (513130), Directory and Mailing List Publishers (513140)
SIC
Books: Publishing Or Publishing & Printing (2731)
akta.pro industry
PRIMARYHLAIAKAK
Pricing Operations & Analytics (Price Governance, Systems, Reporting)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing

Keywords

  • Pharmaceutical market intelligence
  • Healthcare industry research
  • Pharma regulatory guides
  • Market access reports
  • Pharma legal handbooks

Where Pharma Boardroom is headquartered

Location

Headquarters

HQ city
Norwich
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Pharma Boardroom business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others, Technology or R&D

Revenue model

  1. Subscription Membership: The company operates a membership-based model where users must register and sign in to access premium content including reports, interviews, and articles. The registration form indicates subscription terms with automatic renewal at the end of each subscription period.
  2. Report Sales: PharmaBoardroom sells country-specific reports, legal handbooks, and e-books through their Shopify-powered shop. Reports include Country Reports, The Pharma Legal Handbook series, and InFocus e-books covering topics like China biotech catalysts, rare diseases, and regional healthcare trends. Prices range from GBP 75-149 for legal handbooks.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goPharma Legal Handbook Country Reports - Individual country legal guides
One time/ perpetual licensePay-as-you-goMarket Access & HTA Country Reports

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Pharma Boardroom product offering

Product offering

Core offering

PharmaBoardroom produces and sells subscription-based market intelligence for the global pharmaceutical and life sciences industry. Its portfolio includes Country Reports, exclusive executive interviews, The Pharma Legal Handbook series, Market Access & HTA Reports, InFigures statistical datasets, and InFocus e-books covering therapeutic areas and regional market trends across 100+ countries. Premium content is gated behind paid membership, with individual reports and handbooks also sold via a Shopify storefront.

Product overview

PharmaBoardroom is a content and insights platform for the healthcare and life sciences industry, offering a portfolio of content products including Country Reports (country-specific pharmaceutical market analyses), Interviews (exclusive conversations with industry leaders), Articles (news and analysis), The Pharma Legal Handbook (legal and regulatory guides), Market Access & HTA Reports (reimbursement and pricing information), InFigures (statistical data and rankings), InFocus (in-depth e-books), White Papers, and Contributions (opinion content). The platform operates on a subscription model providing access to premium reports and exclusive content to its community of over 26,000 decision-makers, including C-level executives, across the global pharmaceutical industry.

Differentiator

Problem solved

Functional benefit

Products and services

  • Country Reports Comprehensive country-specific reports covering pharmaceutical markets, healthcare systems, and life sciences industries across the Americas, Asia-Pacific, Europe, and Middle East & Africa, targeted at pharma, biotech, and healthcare decision-makers.
  • The Pharma Legal Handbook Comprehensive country-specific legal and regulatory guides covering pharmaceutical law, pricing, reimbursement, marketing, manufacturing, patents, and clinical trial requirements, co-developed with leading national law firms and sold individually (GBP 75-149).
  • Market Access & HTA Reports Country-specific market access and health technology assessment guides covering pricing systems, reimbursement frameworks, managed entry agreements, and healthcare system structures, targeted at market access and HEOR professionals.
  • InFigures Statistical data and rankings including market data, company rankings, regulatory statistics, and pharmaceutical industry metrics across global markets.
  • InFocus (E-books) In-depth focused reports and e-books on specific therapeutic areas, technologies, and regional market trends including cell & gene therapy, precision medicine, rare diseases, and China biotech catalysts.
  • Subscription/Membership Paid annual membership providing access to full reports, downloads, exclusive content, and newsletter subscriptions, with automatic renewal at the end of each subscription period.

Companies that use Pharma Boardroom

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Pharma Boardroom technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Pharma Boardroom partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core.

  • BDK Advokati (Serbia)coreStrategic or Co-development PartnerLegal handbook content partnership. BDK Advokati, a leading Serbian law firm, co-prepared The Pharma Legal Handbook: Serbia, answering questions about legal and regulatory environment for pharmaceuticals in Serbia including regulation, pricing, clinical trials, marketing, manufacturing, trademarks and patents.
  • TEGOS (Baltic Region)coreStrategic or Co-development PartnerLegal handbook content partnership. TEGOS, a leading Baltic law firm, co-prepared The Pharma Legal Handbook: Asia Growth & Transition Market covering Estonia, Latvia and Lithuania, addressing regulation, pricing, clinical and preclinical trials, marketing, manufacturing, trademarks and patents.
  • PRK Partners (Slovakia & Czech Republic)coreStrategic or Co-development PartnerLegal handbook content partnership. PRK Partners, a leading Czech and Slovak law firm, co-prepared The Pharma Legal Handbooks for Slovakia and Czech Republic, covering regulation, pricing, clinical trials, marketing, manufacturing, trademarks, patents, medical cannabis and opioids.
  • Mușat & Asociații (Romania)coreStrategic or Co-development PartnerLegal handbook content partnership. Mușat & Asociații, one of Romania's leading corporate law firms, co-developed the Pharma Legal Handbook: Market Access & HTA Romania, a comprehensive country-specific market access and health technology assessment guide.
  • ABNR (Indonesia)coreStrategic or Co-development PartnerLegal handbook content partnership. ABNR, a leading Indonesian law firm, co-prepared The Pharma Legal Handbook: Asia Growth & Transition Market covering Indonesia.
  • Youssry Saleh Law Firm (Saudi Arabia)coreStrategic or Co-development PartnerLegal handbook content partnership. Youssry Saleh Law Firm, a leading Saudi Arabia law firm, co-prepared the Market Access & Health Technology Assessment: Saudi Arabia guide.
  • Nishimura & Asahi (Japan)coreStrategic or Co-development PartnerLegal handbook content partnership. Nishimura & Asahi, a leading Japanese law firm, co-prepared the Market Access & Health Technology Assessment: Japan guide.
  • Trench Rossi e Watanabe (Brazil)coreStrategic or Co-development PartnerLegal handbook content partnership. Trench Rossi e Watanabe, a leading Brazilian law firm, co-prepared the Market Access & Health Technology Assessment: Brazil guide.
  • Baker McKenzie (Italy)coreStrategic or Co-development PartnerLegal handbook content partnership. Baker McKenzie, a leading Italian law firm, co-prepared the Market Access & Health Technology Assessment: Italy guide.
  • Fangda Partners (China)coreStrategic or Co-development PartnerLegal handbook content partnership. Fangda Partners, a leading Chinese law firm, contributed regulatory content including preclinical and clinical trial requirements, product liability, healthcare system and funding, regulatory reforms, and localization information for China.
  • TGS Baltic (Baltics)coreStrategic or Co-development PartnerLegal handbook content partnership. TGS Baltic, a leading Baltic law firm, co-prepared The Pharma Legal Handbook: Baltics covering Estonia, Latvia and Lithuania.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Pharma Boardroom competitors and assessment

Company assessment

Broad incumbents

  • FiercePharma: FiercePharma is a leading B2B news and analysis outlet for the pharma industry, covering drug commercialization, market access, and policy. It overlaps directly with PharmaBoardroom's editorial remit and global audience, but operates at much larger scale and is part of a broader healthcare B2B portfolio.
  • Citeline (Informa Pharma Intelligence): Citeline, part of Informa Pharma Intelligence, is a large pharma intelligence provider offering databases, analytics, and reports on drug development, clinical trials, and market access. It is a much larger incumbent that addresses a similar buyer need - global pharma market and regulatory intelligence - but via paid data platforms rather than editorial content.
  • GlobalData Healthcare: GlobalData Healthcare provides market intelligence, country reports, and analytics across pharma, biotech, and medtech. It is a direct competitor in the country-specific pharma intelligence segment where PharmaBoardroom sells Country Reports and Market Access & HTA guides, though GlobalData operates at significantly larger scale.
  • The Pink Sheet (Citeline): The Pink Sheet is a flagship pharma policy, regulatory, and market access publication now under Citeline/Informa. It is highly comparable to PharmaBoardroom's Pharma Legal Handbook and Market Access & HTA products in content and buyer, but operates as a subscription news service at much larger scale.
  • Pharma Intelligence / Scrip: Scrip is a long-established pharma industry news and analysis brand under Citeline/Informa, covering global drug development, commercial strategy, and policy. It competes for the same pharma executive readership as PharmaBoardroom, but at much larger institutional scale.

Direct peers

  • BioPharma Dive: BioPharma Dive is a B2B digital publication providing in-depth news and analysis on the biopharma industry, including commercial, regulatory, and R&D coverage. It serves the same C-suite and decision-maker audience as PharmaBoardroom and follows a similar digital-first, subscription-supported model.
  • Endpoints News: Endpoints News is a B2B publication focused on the biopharma industry with deep reporting, editorial analysis, and subscriber-supported business model. It targets similar senior industry professionals and competes for the same pharma executive attention as PharmaBoardroom.
  • PharmaTimes: PharmaTimes is a long-running B2B publication covering the global pharmaceutical industry, including interviews with industry leaders, country features, and market access coverage. It is a like-for-like peer to PharmaBoardroom in editorial format and audience, though it is UK-anchored and more focused on European news.
  • Pharmaceutical Executive: Pharmaceutical Executive is a B2B magazine and digital publication serving senior pharma executives with strategy, policy, and market access content. It targets a similar C-suite audience as PharmaBoardroom and competes for the same executive attention and sponsorship dollars.

Others

  • PharmaBoardroom's direct/adjacent - Focus Reports (legacy sister brand context): Focus Reports appears to share the PharmaBoardroom newsletter infrastructure and content lineage, covering country reports and pharma market analysis. It is a closely related publishing/insights brand rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Pharma Boardroom social profiles

Digital presence

Pharma Boardroom financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pharma Boardroom leadership team

Management profile

Number of profiles

Profiles4 records

Pharma Boardroom funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pharma Boardroom M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma Boardroom

What does Pharma Boardroom do?

PharmaBoardroom produces and sells subscription-based market intelligence for the global pharmaceutical and life sciences industry. Its portfolio includes Country Reports, exclusive executive interviews, The Pharma Legal Handbook series, Market Access & HTA Reports, InFigures statistical datasets, and InFocus e-books covering therapeutic areas and regional market trends across 100+ countries. Premium content is gated behind paid membership, with individual reports and handbooks also sold via a Shopify storefront.

Is Pharma Boardroom a public or private company?

Pharma Boardroom is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Pharma Boardroom founded?

Pharma Boardroom was founded in 2012. It employs 11 to 50 people.

Where is Pharma Boardroom based?

Pharma Boardroom is headquartered in Norwich, United Kingdom, in the Europe region.

How does Pharma Boardroom make money?

Two revenue lines are on record. Subscription Membership is the primary driver. The others are report Sales.

Who are Pharma Boardroom's main competitors?

Broad incumbents on record are FiercePharma, Citeline (Informa Pharma Intelligence), GlobalData Healthcare, The Pink Sheet (Citeline) and Pharma Intelligence / Scrip. Direct peers are BioPharma Dive, Endpoints News, PharmaTimes and Pharmaceutical Executive. PharmaBoardroom's direct/adjacent - Focus Reports (legacy sister brand context) is listed as an others.

Does Pharma Boardroom have an API?

No public API is recorded for Pharma Boardroom.

What industry is Pharma Boardroom in?

Pharma Boardroom's product category is Pharmaceutical Market Intelligence. Its primary akta.pro industry code is HLAIAKAK, Pricing Operations & Analytics (Price Governance, Systems, Reporting). Its NAICS code is 5131 and its SIC code is 2731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePharmaBoardroom Releases 'Healthcare & Life Sciences Review: Spain' September 2019 Pharma ReportPharmaBoardroom released its September 2019 Healthcare & Life Sciences Review: Spain report, which examines trends in the Spanish life sciences sector amid the country's economic rebound.PR NewswirePharmaBoardroom Releases 'Healthcare and Life Sciences Review France' March 2019 Pharma ReportPharmaBoardroom has released a 56-page report, Healthcare & Life Sciences Review France 2019, examining France's USD 65 billion healthcare and life sciences market as an increasingly attractive investment proposition amid Brexit uncertainties and reforms under President Macron's administration. The report features exclusive comments from executives at major French pharmaceutical companies including Ipsen and Sanofi Pasteur, as well as government ministers and regulators, covering topics such as infrastructural investments, digitalization, AI, and France's potential benefits from Brexit.PR NewswirePharmaBoardroom Releases 'Healthcare and Life Sciences Review Algeria' February 2019 Pharma ReportPharmaBoardroom released its 'Healthcare and Life Sciences Review Algeria 2019' report, analyzing Algeria's life sciences sector as a promising investment destination despite past economic challenges. The 63-page document covers topics such as new healthcare laws, local manufacturing localization efforts, and regional export capabilities based on insights from government officials and industry leaders.PR NewswirePharmaBoardroom Releases 'Healthcare and Life Sciences Review Malaysia' December 2018 Pharma ReportPharmaBoardroom released its 46-page Healthcare & Life Sciences Review Malaysia 2018 report, covering the country's pharmaceutical sector performance, investment appeal, and emerging healthcare trends. The report includes exclusive interviews with Malaysia's Minister of Health and the head of the National Pharmaceutical Regulatory Agency (NPRA), examining topics such as halal medicine, biosimilars, clinical research, and medical tourism. The publication highlights both opportunities and challenges, noting Malaysia's strong sector fundamentals despite relatively low healthcare spending and rising non-communicable diseases.PR NewswirePharmaBoardroom Releases 'Healthcare and Life Sciences Review UK' September 2018 Pharma ReportPharmaBoardroom released its 67-page Healthcare & Life Sciences Review UK 2018 report on September 26, 2018, examining the UK's position as a life science investment destination amid Brexit uncertainty. The report covers the government's Life Sciences Industrial Strategy and Sector Deal, the continued R&D investments of multinational pharmaceutical companies, and the role of the NHS in the innovation ecosystem, while also addressing challenges including the EMA's relocation from London and the NHS's slow uptake of innovative treatments.PR NewswirePharmaBoardroom Releases 'Time to Improvise: M&A Megatrends' July 2018 Special ReportPharmaBoardroom released its 34-page special report 'Time to Improvise: M&A Megatrends' on July 19, 2018, providing analysis of merger and acquisition activity in the pharmaceutical industry. The report covers historical megadeals including Teva's purchase of Allergan's generics division, Shire's acquisition of Baxalta, and Johnson & Johnson's $30 million takeover of Actelion, while noting that 2017 was comparatively quiet for pharma M&A. Key trends identified include Big Pharma divesting non-core assets, generics consolidation, major asset swaps, digital asset acquisitions, and increasing consolidation among contract manufacturing organizations.PR NewswirePharmaBoardroom Releases 'Healthcare and Life Sciences Review Malta' 2018 Pharma ReportPharmaBoardroom released its 'Healthcare and Life Sciences Review Malta 2018' report, analyzing the island nation's rapid economic growth driven by a light regulatory environment in the healthcare and life sciences sectors. The report highlights Malta's strategic expansion into niches such as generic pharmaceutical manufacturing, medical tourism, clinical research, and medicinal cannabis production. Interviews with government officials and industry leaders underscore the country's goal to transition into an innovation-based economy while leveraging its geographic position between Europe and Africa.PR NewswirePharmaBoardroom Releases 'Healthcare & Life Sciences Review: Medical Cannabis in Canada'PharmaBoardroom released a 26-page report titled 'Healthcare & Life Sciences Review: Medical Cannabis in Canada' analyzing the growth of the medical cannabis sector. The report highlights that the global market reached USD 70 billion in 2017 and features insights from executives at major Canadian companies such as Tilray, The Cronos Group, and Canopy Health regarding regulatory navigation and international expansion.PR NewswirePharmaBoardroom Releases 'Disruptive Trends in Pharma Regulation' June 2018 Special ReportPharmaBoardroom released a 36-page special report on disruptive trends in pharma regulation, featuring interviews with regulators and industry leaders. The report notes drug development now takes 10-15 years and costs over $2.5 billion on average, and includes topics like regulatory convergence and herbal medicine.PR NewswirePharmaBoardroom Releases 'Healthcare and Life Sciences Review Canada' May 2018 Pharma ReportPharmaBoardroom has released a 58-page report titled 'Healthcare and Life Sciences Review Canada May 2018', providing an in-depth analysis of the Canadian pharmaceutical and life sciences industries. The report covers healthcare reform, regulatory harmonization across provinces, and Canada's emerging strengths in clinical trials, biotech, genomics, medical devices, and cannabinoid-based treatments. According to PwC data cited in the report, the Canadian pharmaceutical market grew 3.5% to USD 22.6 billion during 2015-2016, though challenges remain for generics manufacturers.